{
  "query": "recipients serostatus adverse associated",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT00224484",
          "briefTitle": "Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Simplex"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5960,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "10 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04505722",
          "briefTitle": "A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44325,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05370976",
          "briefTitle": "Efficacy and Safety of CytotectÂ®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cytomegalovirus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ]
  }
}
